Covid live updates: UK begins Oxford-AstraZeneca vaccinations; official more concerned of South Africa variant – CNBC

Some states issue $300 unemployment boost

People gather at the entrance for the New York State Department of Labor offices in Brooklyn on March 20, 2020. The Federal Reserve estimates that 47 million people could lose their jobs before the COVID-19 crisis ends.

Andrew Kelly | REUTERS

Some states have begun paying workers a $300-a-week boost in unemployment benefits, while others signaled it may take a few more weeks or haven’t provided a concrete timeline.

Arizona, California, New York and Rhode Island have either started or will begin disbursing the funds this week, according to state labor officials. Connecticut and Washington state expect to pay the subsidy around mid-January. New Jersey will soon start, after completing user testing, an official said.

The weekly subsidy, which lasts until the middle of March, is provided by the $900 billion Covid relief package President Donald Trump signed recently.

Greg Iacurci

Covid relief bill extends a bundle of tax breaks

Sen. Joe Manchin (D-WV) carries the bill as he gets ready to speak alongside a bipartisan group of Democrat and Republican members of Congress as they announce a proposal for a Covid-19 relief bill on Capitol Hill on December 14, 2020 in Washington, DC.

Tasos Katopodis | Getty Images

Legislators gave taxpayers another chance to nab a package of tax deductions and credits that were set to expire at the end of 2020.

The 5,593-page Covid relief act resurrects a bundle of breaks, known as “tax extenders.”

In all, some 33 provisions would have sunset at the end of last year, including tax breaks on racehorses and write-offs for mortgage insurance.

The pandemic relief legislation made some of these deductions and credits permanent, while others have been extended through 2025.

Tax breaks that will continue to be available to individuals include a package of green tax credits, an exclusion of up to $5,250 for employers’ payments toward workers’ student loans, and an expansion of the lifetime learning credit for families with college students.

Darla Mercado

New York governor to propose law making it a crime to skip vaccine line

New York Gov. Andrew Cuomo said he plans to propose a law that would make it a crime to sell or administer coronavirus vaccine shots to people who are trying to skip ahead in line.

Providers in New York can already lose their license if they fraudulently administer vaccines, though the law would add criminal penalties if approved by the state legislature, he said. So far, health-care workers and people living in nursing homes and assisted living facilities are eligible for Covid-19 vaccines.

“If there’s any fraud in the distribution — you’re letting people get ahead of other people, or friends or family, or they’re selling the vaccine — you’ll lose your license, but I do believe it should be criminal and I’m going to propose a law to that effect,” Cuomo said at a press briefing.

The Democratic governor also pushed for the state’s hospitals to administer the shots faster, saying they could face fines up to $100,000 if they don’t administer their allocated doses by the end of this week.

—Noah Higgins-Dunn

Retail trade group doesn’t see economic activity rebounding to pre-pandemic levels until late 2021

A family walks past people queuing to enter H&M and Nike stores at Citadel Outlets as the coronavirus disease (COVID-19) cases surge in Commerce, California, December 27, 2020.

Bing Guan | Reuters

The National Retail Federation said Monday that overall economic activity is not expected to return to pre-pandemic levels until late 2021, and employment to pre-pandemic levels until well into 2022 or possibly 2023, as the retail industry keeps reeling from the effects of the Covid crisis.

While retail sales for the first 11 months of 2020 — excluding automobile dealers, gasoline stations and restaurants — were up 6.6% year over year, that spending is being distributed highly unevenly, creating a scenario of winners and losers in retail, NRF said. The gap will likely keep widening in the new year.

“As we closed out 2020, it was an end to a whirlwind year whose challenging economic environment will almost certainly continue in 2021,” NRF Chief Economist Jack Kleinhenz said in a statement. “The coming year might be just as eventful as the economic recovery faces many uncertainties. Recoveries do not proceed in a straight line and the prospects for volatility over the next few months are high.”

Kleinhenz added, however, that the retail trade group expects U.S. retail sales to see a boost from the new stimulus. The Trump administration began sending stimulus payments of up to $600 to millions of Americans in late December, as part of the recently passed Covid relief bill. The bill also extended $300 weekly checks for the unemployed for almost three months.

“Consumers responded quickly to last spring’s stimulus checks, and distribution of the new checks will come at a critical time that will help carry 2020’s momentum into 2021,” Kleinhenz said.

The question remains, though, which retailers will see the biggest boost from the checks. NRF has forecast retail sales growth during the holiday season to range between 3.6% and 5.2%. It said final results for the season will be released after the Census Bureau releases December’s sales numbers on Jan. 15.

—Lauren Thomas

Moderna increases minimum 2021 vaccine production to 600 million doses

Moderna is upping the minimum number of doses it expects to make this year by 20% to 600 million, the company said in a statement.

The Massachusetts-based company said it’s working to produce up to 1 billion doses of its Covid-19 vaccine this year. The company is on track to provide the U.S. with 100 million doses of its vaccine by the end of March and an additional 100 million by June, the statement said.

The federal government has agreed to buy 200 million doses of Moderna’s vaccine with the option to secure an additional 300 million doses.

—Noah Higgins-Dunn

BioNTech says there’s no data to support delayed vaccine booster shot offers protection

Ina Siler, a patient at Crown Heights Center for Nursing and Rehabilitation, a nursing home facility, receives the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from Walgreens pharmacist Annette Marshall, in Brooklyn, New York, December 22, 2020.

Yuki Iwamura | Reuters

BioNTech and Pfizer warned that they had no evidence that their jointly developed vaccine will continue to protect against Covid-19 if the booster shot is given later than the amount of time tested in trials, Reuters reports.

“The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design,” the companies said in a joint statement, referring to prime and a booster shots that are meant to be administered three weeks apart.

Terri Cullen

Home prices are rising faster in the middle of the U.S. as Covid drives people from coasts

Home prices continue to climb at a robust clip, but nowhere are home values rising faster than in the middle of the United States, as Covid drives homebuyers from large coastal markets, CNBC’s Diana Olick reports.

Smaller metropolitan markets such as Indianapolis, Kansas City, Boise, Austin, Cleveland, Cincinnati, Memphis and Pittsburgh are seeing some of the strongest price gains in the nation. Prices in those cities are now at least 10% higher than they were a year ago.

Nationally, home prices jumped 8.4% in October from a year earlier on the S&P Case-Shiller Index, the largest one-month move in more than a decade.

“Although the full history of the pandemic’s impact on housing prices is yet to be written, the data from the last several months are consistent with the view that Covid has encouraged potential buyers to move from urban apartments to suburban homes,” Craig Lazzara, managing director at S&P Dow Jones Indices, told CNBC.

Terri Cullen

As cases surge in California, Hollywood pauses TV production

General view of the Hollywood Sign on November 17, 2020 in Hollywood, California.

AaronP/Bauer-Griffin | GC Images | Getty Images

After months of rising coronavirus cases, hospitalizations and deaths in California, several Hollywood guilds and labor unions are recommending that in-person production of television shows and independent films be temporarily halted.

SAG-AFTRA, the Joint Policy Committee and the Producers Guild of America made their recommendation public on Sunday, just days after the regional stay-at-home order in California was extended, with no specific end date.

More than 45,000 new cases were reported in California on Sunday, as the state’s hospitalization rate reached its highest level since the start of the pandemic. Of those new cases, around 12,400 were from Los Angeles County, according to the state’s health department.

“Even putting aside the risk of acquiring COVID on set — a risk that we have done a great deal to mitigate through our safety protocols — on set production always poses some risk of injury, whether because of a stunt gone wrong, an equipment failure or a garden-variety fall,” said David White, SAG-AFTRA’s national executive director. “Right now, with few if any hospital beds available, it is hard to understand how a worker injured on set is supposed to seek treatment.”

Sarah Whitten

Slack is down, causing problems for remote workers

Chat and video service Slack is experiencing an outage. The service began to have trouble around 10 a.m. ET and users around the world are unable to send or receive messages.

Slack has become more important than ever during the pandemic as people continue to rely on remote work solutions.

“We’re continuing to investigate connection issues for customers, and have upgraded the incident on our side to reflect an outage in service,” Slack said in an update at 11:20 a.m. ET. “All hands are on deck on our end to further investigate. We’ll be back in a half-hour to keep you posted.”

—Todd Haselton

Gottlieb makes the case for expanding Covid vaccine eligibility

To speed up coronavirus vaccine distribution in the U.S., former Food and Drug Administration chief Dr. Scott Gottlieb said the government should send out more of its available supply, instead of retaining doses that are earmarked for second shots.

“You need to stockpile something if you want to make sure there’s a smooth transition to the second doses, but putting away 50% of all the doses, I think, is denying more people access to a vaccine,” Gottlieb said on CNBC’s “Squawk Box.”

Gottlieb said that with more supply available states could then offer vaccines to Americans who are at least 65 years old, a high-risk group that appears willing to receive the shots.

“If we have a group of Americans that we know wants the vaccine very badly and would take it quickly and also happens to be at the highest risk of a bad Covid outcome — and I’m thinking in particular about senior citizens in this country — I would just give it to them,” Gottlieb said.

Kevin Stankiewicz

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus and biotech company Illumina. Gottlieb also serves as co-chair of Norwegian Cruise Line Holdings′ and Royal Caribbean’s “Healthy Sail Panel.”

Despite holiday travel spike, airlines have another difficult year ahead

Airlines around the world had a bruising year. U.S. carriers’ 2020 losses alone are expected to top $35 billion and the coming year will be challenging, too.

Air travel spiked over New Year’s weekend to the highest since mid-March despite surging coronavirus cases and warnings from health officials to avoid travel. But airline CEOs have warned that demand will likely wane outside of peak holiday periods until a vaccine is widely available and administered.

Investors will get a better look at airlines’ finances when they start reporting full-year results, which usually begins in mid-January.

—Leslie Josephs

Japan to consider state of emergency for Tokyo area, raising doubt about the Olympics

Commuters wearing masks walk near Shinjuku Station in Tokyo on November 19, 2020.

Kazuhiro Nogi | AFP via Getty Images

Japan is considering declaring a state of emergency for the Greater Tokyo metropolitan area as the number of Covid-19 cases surge, Reuters reports.

The move would cast fresh doubt over whether the country can push ahead with the Olympics this year while keeping economic damage to a minimum, according to Reuters. Kyodo News, citing sources, reported that the state of emergency would take effect on Jan. 9 and last about a month.

Japan logged a record 4,520 new cases on Dec. 31 and at least 3,158 new cases were reported on Sunday, with Tokyo and its surrounding prefectures accounting for about half of them, Reuters reported.

Terri Cullen

U.S. battles deadly surge a year after virus first emerged in China

It’s been just over a year since Chinese health authorities announced they were investigating a small cluster of pneumonia-like cases with an unknown cause.

The coronavirus has now infected more than 85.1 million people across the globe and has killed nearly 1.9 million — counts that are likely lower than official tallies show, global health officials say.

Covid-19 is still surging, but not as much in China, which has reported a weekly average of two Covid deaths a day, according to a CNBC analysis of data compiled by Johns Hopkins University. Meanwhile, the U.S. is reporting an average of 2,637 daily deaths, according to Johns Hopkins.

“I mean, from a public health standpoint, we really got into some significant pain and suffering and death,” White House coronavirus advisor Dr. Anthony Fauci told the “Today” show on Thursday. “The good news is that science has and will come to the rescue by getting us vaccines.”

—Noah Higgins-Dunn

Health experts reluctantly endorse UK decision to delay second vaccine shot

Meghana Pandit, chief medical officer at the Oxford University NHS Trust, right, speaks to Trevor Cowlett, 88, ahead of him receiving the AstraZeneca Plc and the University of Oxford Covid-19 vaccine at the Churchill Hospital in Oxford, U.K., on Monday, Jan. 4, 2021. U.K. regulators cleared the shot last week, marking its first approval worldwide.

Steve Parsons | PA Wire | Bloomberg | Getty Images

The U.K.’s independent Scientific Advisory Group for Emergencies (SAGE) has conditionally backed the U.K.’s decision to delay administering a second dose of the coronavirus vaccine developed by Pfizer and BioNTech.

Late last month, the U.K. said second doses of the Pfizer-BioNTech jab and the newly-approved Oxford-AstraZeneca vaccine, would be given up to 12 weeks after the first dose. Prior to this change of policy, the National Health Service planned to administer a second dose of the Covid-19 vaccine three weeks after the first.

“The urgency of concerted and effective action to suppress the new variant cannot be overstated,” SAGE said in a statement.

“While it is a very difficult and finely balanced decision, Independent SAGE endorses the decision to pursue coverage of as high a proportion of the population as possible, as quickly as possible as part of a comprehensive strategy.”

—Sam Meredith

Here’s how many people have been vaccinated in the U.S. so far

CNBC’s Meg Tirrell reports on the push to speed up coronavirus vaccinations in the United States as the nation lags vaccine rollouts in other countries.

—Melodie Warner 

Health official warns South African Covid variant ‘more of a problem’ than UK strain

A variant of the coronavirus identified in South Africa is more problematic than the strain found in the U.K., Britain’s health minister has said, as both strains continue to spread rapidly.

Speaking to the BBC Monday, Health Secretary Matt Hancock said the variant found in South Africa was especially concerning.

“I’m incredibly worried about the South African variant, and that’s why we took the action that we did to restrict all flights from South Africa,” he told the BBC’s Today program.

“This is a very, very significant problem … and it’s even more of a problem than the U.K. new variant.”

Both the U.K. and South Africa are struggling with a surge in Covid-19 infections, which have been attributed in large part to new mutations in the virus that make it more transmissible.

Holly Ellyatt

UK rolls out Oxford University-AstraZeneca vaccine to the public

82-year-old Brian Pinker receives the Oxford University/AstraZeneca COVID-19 vaccine from nurse Sam Foster at the Churchill Hospital in Oxford as the NHS increases its vaccination program with 530,000 doses of the newly approved jab available for rollout across the UK on January 4, 2021 in London, England. (Photo by Steve Parsons – WPA Pool/Getty Images)

Steve Parsons | WPA Pool | Getty Images News | Getty Images

The U.K. has begun the rollout of the coronavirus vaccine developed by AstraZeneca and the University of Oxford, marking another step in the fight against the coronavirus pandemic.

The jab was approved for use in the U.K. by the Medicines and Healthcare products Regulatory Agency last week and 82-year-old Brian Pinker was the first person in the world to receive the vaccine.

The deployment of the Oxford-AstraZeneca vaccine is seen as a boon in the race against Covid-19 as it is cheaper than alternatives created by Pfizer and BioNTech, and Moderna.

Unlike rival vaccines, the Oxford-AstraZeneca vaccine can be stored, transported and handled at normal refrigerated conditions (2 to 8 degrees Celsius or 36 to 46 degrees Fahrenheit) for at least six months. The U.K., which has a population of around 66 million, has pre-ordered 100 million doses, meaning there will be enough for 50 million people.

Holly Ellyatt

Read CNBC’s previous live coverage here:


Related posts